EACVI Premium Access

Evaluation of left ventricular filling pressure by echocardiography: incremental diagnostic information from left atrial strain

Congress Session

About the speaker

Doctor Faraz Khan

Oslo University Hospital Rikshospitalet, Oslo (Norway)
1 follower

8 more presentations in this session

Relationship between myocardial properties and myocardial stiffness in hearts with thick walls: a shear wave imaging study using ultra-high frame rate echocardiography

Speaker: Doctor M. Cvijic (Ljubljana, SI)

Thumbnail

Impaired preload reserve is an important haemodynamic characteristics that discriminates between physiological ageing and overt heart failure with preserved ejection fraction

Speaker: Doctor A. Shono (Kobe, JP)

Thumbnail

Multimodality imaging approach by speckle tracking echocardiography and cardiac magnetic resonance of heart failure with preserved ejection fraction, a step forward

Speaker: Associate Professor R. Rimbas (Bucharest, RO)

Thumbnail

Time to solve the puzzle of heart failure with preserved ejection fraction by biomarkers, echocardiography and cardiac magnetic resonance

Speaker: Associate Professor R. Rimbas (Bucharest, RO)

Thumbnail

Closed-chest measurement of diastolic and systolic shear wave speed to assess myocardial stiffness

Speaker: Doctor A. Caenen (Ghent, BE)

Thumbnail

Access the full session

Live Abstract Presentations - HFpEF

Speakers: Doctor F. Khan, Doctor M. Cvijic, Doctor A. Shono, Associate Professor R. Rimbas, Associate Professor R. Rimbas...
Thumbnail

About the event

Image

EACVI - Best of Imaging 2020

11 December - 12 December 2020

Sessions Presentations

Related content

ESC Premium Access

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

28 August 2021

Open Access

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - panel .

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

This platform is supported by

logo Novo Nordisk